 |
Articles: Chemotherapy/Oncology |
Prior Articles
Drug Targeting Through Pilosebaceous Route
Current Drug Targets, 10/23/09
Targeting Sarcomas: Novel Biological Agents and Future Perspectives
Current Drug Targets, 10/23/09 Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09 First-Line Treatment of Multiple Myeloma in Elderly Patients: the GIMEMA Multiple Myeloma Working Party Perspective
Current Drug Targets, 10/23/09 Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Current Drug Targets, 10/23/09 Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
British Journal of Clinical Pharmacology, 10/22/09 FAU regulates carboplatin resistance in ovarian cancer
Genes, Chromosomes and Cancer, 10/22/09 Palliative Oncology: Thalidomide
American Journal of Hospice and Palliative Medicine, 10/21/09 A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever
Journal of Medical Microbiology, 10/21/09 Impact of Preoperative Bevacizumab on Complications After Resection of Colorectal Liver Metastases: Case-Matched Control Study
World Journal of Surgery, 10/21/09 Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908
Annals of Oncology, 10/20/09 Global drug development in cancer: a cross-sectional study of clinical trial registries
Annals of Oncology, 10/20/09 Combination of radiotherapy and chemotherapy in locally advanced NSCLC
Expert Review of Anticancer Therapy, 10/20/09 Luteinizing hormone-releasing hormone agonists in the treatment of breast cancer
Expert Opinion in Pharmacotherapy, 10/19/09 FDA approves Cervarix, GlaxoSmithKlines cervical cancer vaccine
GlaxoSmithKline, 10/19/09
Free full text
Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
Clinical Cancer Research, 10/19/09 Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting
Bulletin du Cancer, 10/19/09 Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09 Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends
Clinical Therapeutics, 10/15/09 Prospects of stem cell therapy for replacing dopamine neurons in Parkinsons disease
Trends in Pharmacological Sciences, 10/15/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
